Alopexy 5%

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alopexy 5%

Quick Facts

Property Description
Active ingredient Minoxidil
Form Cutaneous solution (Topical liquid)
Pharmacological class Anti-alopecia agent; Peripheral vasodilator
Common use Management of hair thinning (Androgenetic alopecia)
Origin Synthetic pyrimidine derivative

What is Alopexy 5% and What is its Pharmacological Type?

Alopexy 5% is a single-ingredient dermatological medicine formally classified as an anti-alopecia agent and a hair growth stimulant. This medicine contains the active substance Minoxidil, which is a synthetic compound derived from the pyrimidine derivative family. The ingredient Minoxidil is clinically recognized for its therapeutic application in managing hair loss. Its original classification as a powerful vasodilator established the foundation for its subsequent topical development, positioning it as a unique agent in the dermatological landscape.

Composition and Form: Minoxidil in a Cutaneous Solution

The primary active component of Alopexy 5% is Minoxidil, delivered at a 5% concentration within an alcoholic cutaneous solution. This formulation is a liquid preparation explicitly designed for localized dermal application to the scalp. The 5% concentration is generally positioned for use in adult men, offering a distinct strength profile compared to lower concentration forms. As a single-ingredient product, it relies entirely on the established efficacy of Minoxidil, utilizing an alcoholic solution vehicle for targeted absorption, ensuring efficient delivery of the active substance to the hair follicles.

General Purpose: Defining the Benefit of this Anti-Alopecia Agent

The general purpose of Alopexy 5% is to manage hair thinning by supporting the stimulation of hair follicle growth and vitality. The medicine’s core action involves its property as a peripheral vasodilator, which increases local blood flow to the follicular unit. This effect is instrumental in counteracting the process of hair miniaturization often seen in androgenetic alopecia. By providing a supportive and vascularized environment, the product is designed to slow the progressive nature of pattern baldness and promote the growth of thicker, more substantial hair.

Regulatory References

  1. Minoxidil 5% w/v cutaneous spray, solution - SmPC

What side effects are possible with Alopexy 5%?

Possible Side Effects and Safety Information

The safety profile of topical Minoxidil 5% is organized by regulatory authorities based on the frequency and system-organ class of reported reactions. The most frequently documented adverse effects primarily involve the skin and nervous system.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Reactions
Very Common (ge 1/10) Headache; Hypertrichosis (unwanted non-scalp hair growth)
Common (ge 1/100 to < 1/10) Local skin irritation; Pruritus (itching); Dermatitis; Peripheral Oedema (swelling)
Uncommon / Rare Dizziness; Chest Pain; Tachycardia (increased heart rate); Hypotension (low blood pressure)

Systemic and Cardiovascular Safety

Although the medicine is applied topically, official labeling notes the potential for systemic absorption that can lead to more serious effects related to the Cardiac and Vascular Systems. These rare but documented reactions include significant hypotension, tachycardia, and severe chest pain. These effects are consistent with the known peripheral vasodilator activity of Minoxidil.

Population and Use Restrictions

The official safety information establishes specific constraints. The medicine is not indicated for use in individuals under 18 years of age and is not recommended for women due to the higher risk of hypertrichosis. Furthermore, caution or contraindication is required for individuals with pre-existing cardiovascular diseases. The product should also not be applied to a scalp that is inflamed, irritated, or injured, as this increases the risk of systemic absorption.

Time-Related Safety Patterns

A transient increase in hair shedding is noted in regulatory documents and may be observed during the initial two to six weeks of treatment. Local reactions, such as irritation and pruritus, are also often reported more frequently during the start of therapy.

Overdose and Emergency Response

The official regulatory profile for Alopexy 5% overdose centers on the risk of systemic effects resulting from excessive absorption or, most severely, accidental oral ingestion of the solution. This risk is due to the potent peripheral vasodilatory nature of the active substance.

Documented Overdose Manifestations

Overdose may present with specific cardiovascular signs, including hypotension (low blood pressure), tachycardia (rapid heartbeat), dizziness, faintness, and chest pain. Other documented signs involve fluid balance disturbances, such as sudden, unexplained weight gain and swelling of the hands or feet (oedema). Regulatory documents warn that accidental ingestion, particularly by young children, carries the risk of serious injury or death from poisoning.

Regulator-Mandated Emergency Actions

Regulators explicitly mandate seeking medical attention if specific systemic symptoms occur during topical use, such as the appearance of chest pain, rapid heartbeat, or unexpected swelling. For cases of accidental ingestion, the instruction is to seek professional assistance or contact a Poison Control Center immediately. Management of documented overdose requires professional symptomatic and supportive care. This may include the use of intravenous normal saline for hypotension, and the administration of beta-adrenergic blocking agents or appropriate diuretic therapy to manage cardiac and fluid effects, as described in official prescribing information.

Therapeutic Uses of Alopexy 5%

Alopexy 5% is a topical solution used in the therapeutic domain where supportive symptom management is appropriate for certain hair-related symptoms that interfere with daily functioning. The active ingredient, minoxidil 5%, is commonly used to help with the management of conditions involving episodic or fluctuating manifestations, specifically male pattern hair loss (androgenetic alopecia).

The primary context for this formulation is relevant for easing symptoms associated with moderate androgenetic alopecia in adult male subjects. The product supports patients during difficult episodes by easing distress and is relevant when symptoms become more noticeable. The overall intent is that the product contributes to easing the overall symptom burden and helps improve day-to-day comfort during symptomatic periods.


The treatment is considered relevant in scenarios where additional management of discomfort is required, and is commonly used when short-term symptomatic assistance is needed. The formulation assists with maintaining functional stability and supports general well-being during symptomatic phases.


Quick Fact: Supportive care for symptoms related to physical discomfort

Regulatory References

  1. Public Assessment Report by the MHRA

Eligibility and Restrictions for Use

Eligibility for Alopexy 5% (Minoxidil Solution)

Official regulatory information strictly defines the population that can use Alopexy 5%, which is indicated only for adult men between the ages of 18 and 65 who have been diagnosed with hereditary male pattern hair loss (androgenetic alopecia).

Contraindicated Populations Use Is Not Recommended
Individuals with allergy/hypersensitivity to minoxidil or excipients Women, due to risk of hypertrichosis (unwanted hair growth)
Patients who showed intolerance to the Minoxidil 2% solution Individuals under 18 or over 65 years of age
Those with a red, inflamed, infected, or painful scalp Patients with non-hereditary, sudden, or patchy hair loss

Use is also contraindicated during pregnancy and breastfeeding due to potential risks, and the product must not be used concurrently with other topical treatments on the scalp. Patients with a known history of heart disease or hypertension must consult a physician prior to starting treatment.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory documents define the interaction profile of Alopexy 5% based strictly on its topical application, the potential for systemic absorption, and metabolic pathways. Interactions are classified by how they modify the skin barrier, the drug's metabolic activation, or its peripheral vascular effects.

Topical and Absorption-Modifying Interactions

The co-administration of Alopexy 5% with other medicinal products applied to the scalp is strictly prohibited. This restriction is due to the potential for increased systemic exposure. Substances known to enhance the permeability of the skin barrier, such as Tretinoin and Dithranol (Anthralin), are documented to significantly increase the percutaneous absorption of minoxidil, potentially leading to higher systemic concentrations.

Interactions Affecting Efficacy and Systemic Effects

Co-administration with Low-Dose Acetylsalicylic Acid (Aspirin) may diminish the therapeutic effectiveness of Alopexy 5%. This interaction is associated with the inhibition of enzymes required to convert minoxidil to its active form in the scalp.

Furthermore, caution is advised when Alopexy 5% is used concurrently with systemic antihypertensive agents, including Guanethidine or Betanidine, due to the potential for an additive hypotensive effect if minoxidil is absorbed systemically. The combination with Systemic Cyclosporine has also been documented to exacerbate the adverse effect of hypertrichosis.

Mechanism of Action

The Pharmacodynamic Mechanism of Alopexy 5%

The active metabolite, minoxidil sulfate, modulates core cellular processes in the scalp. This metabolite functions as an opener of ATP-sensitive potassium channels ( K ATP) in vascular smooth muscle cells, leading to localized arteriolar vasodilation. This change in perfusion regulates the metabolic supply to the follicular unit.

Simultaneously, the drug acts directly on the dermal papilla cells to influence the hair growth cycle. It promotes the transition of hair follicles from the resting (telogen) phase into the active growth (anagen) phase and prolongs the duration of the anagen phase. This action is supported by the up-regulation of growth factors, such as Vascular Endothelial Growth Factor ( VEGF), which modifies signaling pathways and influences factors that encourage premature cellular senescence and apoptosis within the follicle.

Dosage and Administration Information

How to Use Alopexy 5% Cutaneous Solution

Instructions for Alopexy 5% (minoxidil) detail a precise administration schedule and technique for treating androgenetic alopecia.

Standard Dosing and Frequency

Parameter Instruction
Route Topical (Cutaneous) use only.
Unit Dose 1 mL of the 5% solution.
Frequency Twice daily (morning and evening).
Maximum Daily Dose Must not exceed 2 mL.

Applications should be spaced by approximately 12 hours. The dose and frequency should not be increased beyond the recommended limits.

Application Procedure and Technique

The solution must be applied only to the completely dry hair and scalp. The unit dose of 1 mL is measured using the graduated dropper or pump applicator provided with the product. The solution is distributed over the center of the area to be treated. Hands must be washed thoroughly immediately after application to prevent unintentional transfer to other body areas.

After applying Alopexy 5%, the scalp must be allowed to dry completely before going to bed, styling hair, or wearing a hat. Hair should not be washed for at least four hours following application. The use of a hairdryer to accelerate drying is not recommended, as it may reduce the effectiveness of the product. If a dose is missed, patients should resume the regular twice-daily schedule without attempting to apply a double dose.

Age-Specific Use

Alopexy 5% is generally intended for men aged 18 to 65 years. Its use is not recommended for individuals under 18 or over 65, as safety and efficacy have not been established in these age groups.

Recent Clinical Evidence

Topical Alopexy 5% contains the active substance minoxidil and is indicated for the treatment of moderate androgenetic alopecia (male pattern baldness) in men. A 5% concentration of topical minoxidil has been consistently demonstrated in clinical trials to be more effective than the 2% concentration in promoting hair regrowth and slowing hair loss in men. The superiority of the 5% formulation is typically measured by an increase in non-vellus (terminal) hair count in the target area of the scalp.

Efficacy and Response

Clinical studies have shown that 5% topical minoxidil, when applied twice daily, provides significant improvements in hair density and coverage compared to placebo. A noticeable response usually requires continuous use for at least four months, with maximum benefits often observed after twelve to fifteen months of therapy. Patients who exhibit the best response are generally those with a recent onset of hair loss and smaller areas of baldness.

Safety Profile

The most common side effects associated with topical minoxidil 5% are local reactions, including scalp irritation, pruritus (itching), and contact dermatitis. These are often linked to excipients like propylene glycol present in the solution form. Although the 5% concentration is associated with a higher incidence of local irritation than the 2% concentration, it is generally well-tolerated. Systemic effects are rare due to minimal absorption through the scalp but may include transient symptoms such as headache, dizziness, or peripheral edema in susceptible individuals. The drug is generally not recommended for use by women due to a higher risk of hypertrichosis (unwanted facial hair growth).

Frequently Asked Questions (FAQ)

Common questions about Alopexy 5% (FAQ)

Q: How long does it usually take to see any effect from Alopexy 5%?

Studies and official information indicate that a noticeable response typically requires continuous application for at least four months. The maximum benefits are often observed after twelve to fifteen months of consistent use.

Q: What happens if I stop using Alopexy 5%?

Regulatory documents state that the results achieved with this product depend upon its continuous application. If the treatment is discontinued, the therapeutic effect will be lost, and a return to the prior state of hair loss is generally expected.

Q: Can I use hair styling products after applying Alopexy 5%?

Official guidance advises allowing the scalp to dry completely after applying the solution before styling hair or using other hair care products. This step helps reduce the risk of unintentionally transferring the product to other areas or decreasing local effectiveness.

Q: Can I use Alopexy 5% if I have an existing scalp condition like psoriasis?

Official information advises against using the product on a scalp that is inflamed, irritated, infected, or injured. The presence of existing scalp conditions may increase the risk of the product being absorbed into the body. The presence of pre-existing scalp conditions is a factor to discuss with a healthcare professional.

Q: What should I do if I accidentally get Alopexy 5% in my eyes?

Regulatory safety information advises that if the solution comes into contact with the eyes, sensitive areas, or any mucosal surface, the affected area should be rinsed immediately and thoroughly with large amounts of cool tap water.

Q: Does Alopexy 5% require a prescription in most places?

In many regions, the 5% minoxidil solution is generally available for purchase without a prescription for use in men. However, the regulatory status of medicines, including prescription requirements, can vary significantly depending on the country.

Q: Are there any common reasons why Alopexy 5% might not work for someone?

Official documents note that the product may not work for every user who tries it. Clinical evidence suggests that the best responses are typically observed in individuals with a recent onset of hair loss and smaller areas of thinning. It is not indicated for hair loss that is non-hereditary, sudden, or patchy.

Q: Does sun exposure change how Alopexy 5% works?

Some official guidance suggests that using this product may make the skin of the scalp more sensitive to sunlight. Protective measures, such as wearing a hat or covering the treated area, may be discussed with a healthcare professional when sun exposure is a concern.

Q: Is Alopexy 5% safe to use if I have sensitive skin?

Official safety profiles list local skin reactions, such as irritation, redness, and itching, as common side effects. These reactions are sometimes linked to ingredients like propylene glycol. If persistent irritation occurs, further guidance from a healthcare professional may be needed.

Q: Is Alopexy 5% a lifetime commitment once started?

The official product information indicates that continuous application is necessary to maintain hair regrowth and slow the rate of hair loss. If the use of the product is discontinued, the effects are likely to reverse over time.

Q: Does Alopexy 5% have any known serious interactions with supplements?

Regulatory documents state that it is important to disclose all medications, including non-prescription products and nutritional supplements, to a healthcare professional. This is a common precaution to prevent potential effects, such as additive effects on blood pressure, especially if minoxidil is absorbed systemically.

Q: What is the difference between Alopexy liquid and foam formulations?

The core difference between the liquid solution and potential foam formulations is typically found in the non-active ingredients, or excipients. Foam preparations sometimes omit excipients like propylene glycol, which are occasionally linked to local scalp irritation in the liquid solution.

Q: How quickly is Alopexy 5% absorbed into the scalp?

Official application instructions require the product to dry completely on the scalp after application, which can take a number of hours. This drying period is generally associated with the time needed for the active substance to be absorbed into the hair follicles.

Q: Does Alopexy 5% work on a receding hairline or just the crown?

The medicine is officially indicated for the treatment of moderate hereditary male pattern baldness. While its efficacy is well-established for the crown of the head (vertex), regulatory summaries suggest that the effects may be less robust on a receding frontal hairline.

Q: Is it true that Alopexy 5% can cause facial hair growth?

Yes, official safety documentation lists hypertrichosis, which is unwanted non-scalp hair growth, as a very common side effect. Regulatory sources confirm that this has been documented to include the growth of hair on the face.

Q: Are there any documented long-term side effects of Alopexy 5% use?

Official safety profiles document both common local reactions and rare systemic effects based on data collected over time. Regulatory authorities continuously monitor adverse reactions through post-marketing surveillance, which captures information on effects from long-term use.

Q: Can Alopexy 5% be used if I have colored or treated hair?

Regulatory guidance suggests that, in some users, the product may cause subtle changes in hair color or texture. Specific application and drying instructions are provided to help minimize any potential cosmetic changes to treated or colored hair.

Q: How long does a typical bottle of Alopexy 5% last?

Based on the standard recommended maximum daily dose of 2 mL, and assuming a standard 60 mL packaging volume, a single bottle is generally intended to provide a 30-day course of treatment.

Q: Does Alopexy 5% interact with common headache medications?

Official labeling specifically notes that co-administration with low-dose Acetylsalicylic Acid (Aspirin) may interfere with the medicine's effectiveness. Official guidance emphasizes the need to disclose all medicines, including common over-the-counter pain relievers, to a healthcare provider.

Q: Is Alopexy 5% absorbed systemically (into the whole body) after scalp application?

Yes, regulatory documents confirm that a small amount of the active substance is absorbed into the bloodstream after application to the scalp. This minimal systemic absorption is why rare side effects related to the heart and vascular system are documented.

Q: Does Alopexy 5% contain parabens or other preservatives?

A full list of all non-active ingredients, or excipients, is provided in the official product information and patient leaflets. Patients can consult these documents to check for the presence of specific preservatives like parabens.

Q: Is Alopexy 5% designed for permanent or temporary hair loss issues?

The product is indicated for the management of hereditary male pattern hair loss (androgenetic alopecia). Since this is a chronic and progressive condition, continued use is necessary to maintain the positive results.

Q: How does Alopexy 5% fit into a general hair care routine?

Official application instructions require the product to be applied to a completely dry scalp, and the head should not be washed for at least four hours following application. These necessary application conditions dictate how the product must be incorporated into a person's regular hair care and washing routine.

Q: Are there any regulatory warnings about using Alopexy 5%?

Yes, regulatory documents contain specific warnings. These warnings cover risks such as local irritation, the potential for rare systemic effects, and contraindications against use in individuals with pre-existing heart conditions or an irritated scalp.

Q: Why does the Alopexy 5% solution sometimes have a yellow color?

Official product descriptions typically describe the solution as colorless to slightly yellow. This slight coloration is generally linked to the non-active ingredients, or excipients, present in the alcoholic solution base of the product.

Q: Does Alopexy 5% have an odor?

The product is formulated as an alcoholic solution, and the resulting odor is associated with the high alcohol content required for the solution vehicle. This component aids in the product's application and delivery.

Q: Is it normal for the scalp to feel slightly warm after applying Alopexy 5%?

Official safety documents list local irritation, including itching and dermatitis, as common side effects. A mild warming sensation may be related to the application of the alcoholic solution base or these reported local reactions.

How should Alopexy 5% be stored and disposed of?

How to Store and Dispose of Alopexy 5%?

The storage and disposal of Alopexy 5% solution must adhere strictly to the conditions specified in the official regulatory documentation.

Storage Requirements and Stability

The medicine must be kept out of the sight and reach of children due to risks associated with accidental ingestion. The topical solution is officially classified as a flammable product, requiring appropriate handling.

Regarding stability, the product must not be used after the labeled expiry date. Once the bottle has been first opened, the solution must be used within one month.

Official Disposal Rules

To protect the environment, medicinal products must not be disposed of in waste water or regular household waste. Patients are instructed to consult their pharmacist on how to properly dispose of the medicine when it is no longer required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alopexy 5% found in:

A-Z Index: